Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Catanzaro

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Pharmacy Practice|April 29, 2022
An Examination of Student Pharmacists' Perceptions Toward ImmunizationMichael Danilov, Kira Voyer, Linda M Catanzaro, et al.
Current Research in Pharmacology and Drug Discovery|December 15, 2021
Pharmacokinetic drug interactions of integrase strand transfer inhibitorsChi-Hua Lu, Edward M Bednarczyk, Linda M Catanzaro, et al.
Bibliotheca Cardiologica|January 1, 1989
Coronary hemodynamic effects of chemical mediators of allergic and inflammatory reactions in manC Vigorito, A Giordano, E Casaburi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 1, 1996
[Conservative treatment of high-risk (T1G3) transitional carcinoma]F Catanzaro, F Torelli, M Catanzaro, et al.
Plos One|April 29, 2011
Elevated expression of squamous cell carcinoma antigen (SCCA) is associated with human breast carcinomaJoseph M Catanzaro, Jennifer L Guerriero, Jingxuan Liu, et al.
Current Pharmaceutical Design|March 7, 2006
Update on the pharmacokinetic aspects of antiretroviral agents: implications in therapeutic drug monitoringJ C Slish, L M Catanzaro, Q Ma, et al.
Clinical Pharmacokinetics|March 1, 2008
Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairmentSarah M McCabe, Qing Ma, Judianne C Slish, et al.
American Heart Journal|September 1, 1988
Regional coronary hemodynamic effects of diltiazem in manC Vigorito, A Giordano, L De Caprio, et al.
Oxidative Medicine and Cellular Longevity|May 5, 2018
Characterization of the Antioxidant Effects of <i>γ</i>-Oryzanol: Involvement of the Nrf2 PathwayW Rungratanawanich, G Abate, M M Serafini, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitorsQing Ma, Olanrewaju O Okusanya, Patrick F Smith, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Pharmacy Practice|April 29, 2022
An Examination of Student Pharmacists' Perceptions Toward ImmunizationMichael Danilov, Kira Voyer, Linda M Catanzaro, et al.
Current Research in Pharmacology and Drug Discovery|December 15, 2021
Pharmacokinetic drug interactions of integrase strand transfer inhibitorsChi-Hua Lu, Edward M Bednarczyk, Linda M Catanzaro, et al.
Bibliotheca Cardiologica|January 1, 1989
Coronary hemodynamic effects of chemical mediators of allergic and inflammatory reactions in manC Vigorito, A Giordano, E Casaburi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 1, 1996
[Conservative treatment of high-risk (T1G3) transitional carcinoma]F Catanzaro, F Torelli, M Catanzaro, et al.
Plos One|April 29, 2011
Elevated expression of squamous cell carcinoma antigen (SCCA) is associated with human breast carcinomaJoseph M Catanzaro, Jennifer L Guerriero, Jingxuan Liu, et al.
Current Pharmaceutical Design|March 7, 2006
Update on the pharmacokinetic aspects of antiretroviral agents: implications in therapeutic drug monitoringJ C Slish, L M Catanzaro, Q Ma, et al.
Clinical Pharmacokinetics|March 1, 2008
Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairmentSarah M McCabe, Qing Ma, Judianne C Slish, et al.
American Heart Journal|September 1, 1988
Regional coronary hemodynamic effects of diltiazem in manC Vigorito, A Giordano, L De Caprio, et al.
Oxidative Medicine and Cellular Longevity|May 5, 2018
Characterization of the Antioxidant Effects of <i>γ</i>-Oryzanol: Involvement of the Nrf2 PathwayW Rungratanawanich, G Abate, M M Serafini, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitorsQing Ma, Olanrewaju O Okusanya, Patrick F Smith, et al.
Pageof 6